CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Mercury Laboratories Ltd.

NSE : BSE : 538964 ISIN CODE : INE947G01011Industry : Pharmaceuticals

News

  • Mercury Laboratories Q3 net profit down 15.97% at Rs 1.00 cr 11 Feb 2026 | 13:00 | Dion Global

    The company reported standalone net profit of Rs 1.00 crore for the quarter ended December 31 2025 as compared to Rs 1.19 crore in the same period la...more...

  • Mercury Laboratories - Results- Financial Results As On December 31, 2025 11 Feb 2026 | 11:27 | Dion Global

    Unaudited Financial Results as on December 31 2025 is attachedmore...

  • Mercury Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On 11.02.2026 11 Feb 2026 | 11:23 | Dion Global

    Outcome of Board Meeting held on February 11 2026 is attachedmore...

  • Mercury Laboratories - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months E 04 Feb 2026 | 16:41 | Dion Global

    Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to ...more...

  • Mercury Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025 09 Jan 2026 | 17:40 | Dion Global

    As of December 2025 73.66% is owned by Indian Promoters and 26.34% by Public. Top five Promoters holding highest number of shares of Mercury Laborato...more...

  • Mercury Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 03 Jan 2026 | 16:22 | Dion Global

    Compliance certificate under Reg 74(5) SEBI(DP) Reg 2018 for the quarter ended on December 31 2025 is attachedmore...

  • Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management 17 Nov 2025 | 18:19 | Dion Global

    Intimation about additional charge assigned to Mr. Saurabh Mittal as VP-marketing & Sales is attachedmore...

  • Mercury Laboratories Q2 net profit zooms 228.00% at Rs 1.64 cr 11 Nov 2025 | 19:42 | Dion Global

    The company reported standalone net profit of Rs 1.64 crore for the quarter ended September 30 2025 as compared to Rs 0.50 crore in the same...more...

  • Mercury Laboratories - Updates On New Small Volume Parenteral (Svps) Plant At Jarod 11 Nov 2025 | 19:32 | Dion Global

    Updates on new injectable plants is attachedmore...

  • Mercury Laboratories - Unaudited Financial Results For The Quarter And Half Year Ended On September 2025 11 Nov 2025 | 19:27 | Dion Global

    Unaudited Financial Results for the quarter and half year ended on September 2025 is attachedmore...

  • Mercury Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On November 11, 2025 11 Nov 2025 | 19:16 | Dion Global

    Outcome Of Board Meeting Held On November 11 2025 is attachedmore...

  • Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management 07 Nov 2025 | 16:25 | Dion Global

    Intimation of Resignation of Mr. Mukesh Shrivastva VP-sales and Marketing is attachedmore...

  • Mercury Laboratories - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter And Half Year 05 Nov 2025 | 10:21 | Dion Global

    Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider ...more...

  • Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management 04 Nov 2025 | 17:28 | Dion Global

    Intimation of an appointment of Ms. Seema salvi as Head of Department(Injection production) is attachedmore...

  • Mercury Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025 15 Oct 2025 | 17:10 | Dion Global

    As of September 2025 73.66% is owned by Indian Promoters and 26.34% by Public. Top five Promoters holding highest number of shares of Mercury Laborat...more...

  • Mercury Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 06 Oct 2025 | 14:20 | Dion Global

    Certificate under Reg 74(5) of SEBI(DP)Reg 2018 for the quarter ended on September 30 2025 is attachedmore...

  • Mercury Laboratories - Communication To Shareholders Regarding 100 Days Campaign - 'Saksham Niveshak' 04 Oct 2025 | 10:24 | Dion Global

    Communication regrading 100 days campaign - Saksham Niveshak is attachedmore...

  • Mercury Laboratories - Communication To Shareholders Regarding 100 Days Campaign - 'Saksham Niveshak' 04 Oct 2025 | 10:24 | Dion Global

    Communication regrading 100 days campaign - Saksham Niveshak is attachedmore...

  • Mercury Laboratories - Communication To Shareholders Regarding 100 Days Campaign - 'Saksham Niveshak' 04 Oct 2025 | 10:24 | Dion Global

    Communication regrading 100 days campaign - Saksham Niveshak is attachedmore...

  • Mercury Laboratories - Communication To Shareholders Regarding 100 Days Campaign - 'Saksham Niveshak' 04 Oct 2025 | 10:24 | Dion Global

    Communication regrading 100 days campaign - Saksham Niveshak is attachedmore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex74563.92-1.93%
NSE Index23151.1-2.06%
B500DIVL503456.14-2.58%
BSE 1000 9930.73-2.32%
BSE 100LCTMC8618.83-2.15%
BSE Auto 53876.79-3.27%

Commodity

Gold158013-1.12%
Silver260297-3.09%
Copper1230.5201.74%
Crude Oil884137.86%
Lead19444.35%
Mentha Oil1060.7-0.63%
Nickel1637.3113.50%

Currency

USD/INR 92.35(0.46 %)
GBP/INR 123.47(-0.13 %)
EUR/INR 106.62(-0.31 %)
JPY/INR 0.58(-0.36 %)
CAD/INR 67.91(0.49 %)
HKD/INR 11.80(0.44 %)